Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat

Journal of the American College of Cardiology

Volumn 42, Issue 2, 2003, Pages 336-344

  Boixel, Christophe ^a   Fontaine, Vincent ^a   Rücker Martin, Catherine ^c   Milliez, Paul ^d   Louedec, Liliane ^a   Michel, Jean Baptiste ^a   Jacob, Marie Paule ^a   Hatem, Stéphane N ^a,b,e  

^a INSERM   (France)

^b Serv d'Explorations Fonctionnelles   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM; HEART ATRIUM ENLARGEMENT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEMODYNAMICS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 0038300656     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00578-3     Document Type: Article

References (39)

1. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. Atrial fibrillation: current understandings and research imperatives. J Am Coll Cardiol 1993;22:1830-4.
2. Boutjdir M, Le Heuzey JY, Lavergne T, et al. Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? Pacing Clin Electrophysiol 1986;9:1095-100.
3. Ausma J, Wijffels M, Thoné F, Wouters L, Allesie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-63.
4. Aimé-Sempé C, Folliguet T, Rücker-Martin C, et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 1999;34:1577-86.
5. Li D, Fareh S, Leung TL, Nattel S. Promotion of atrial fibrillation by heart failure in dogs. Atrial remodeling of a different sort. Circulation 1999;100:87-95.
6. Rücker-Martin C, Pecker F, Godreau D, Hatem SN. Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro. Cardiovasc Res 2002;55:38-52.
7. Kostin S, Klein G, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-79.
8. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular diseases. Circ Res 1995;77:863-8.
9. Spinale FG, Coker ML, Thomas CV, Walker JD, Mukherjee R, Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure. Relation to ventricular and myocyte function. Circ Res 1998;82:482-95.
10. Li YY, Feldman AM, Sun Y, McTiernan CF. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 1998;98:1728-34.
11. Creemers E, Cleutjens J, Smits J, Daemen M. Matrix metalloproteinases inhibition after myocardial infarction. Circ Res 2001;89:201-10.
12. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002;90:520-30.
13. Spinale FG, Coker ML, Krombach SR, et al. Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circ Res 1999;85:364-76.
14. Rhode LE, Ducharme A, Arroyo LH, et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999;99:3063-70.
15. Michel J-B, Lattion A-L, Salzmann J-L, et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988;62:641-50.
16. Prunier F, Gaertner R, Louedec L, Michel JB, Mercadier JJ, Escoubet B. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol 2002;283:H346-52.
17. Boixel C, Gonzalez W, Louedec L, Hatem SN. Mechanism of the down regulation of the L-type calcium current in atrial myocytes of rat in heart failure. Circ Res 2001;89:607-13.
18. Michel J-B, Mercadier J-J, Galen F-X, et al. Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats. Cardiovasc Res 1990;24:946-52.
19. Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol 2000;192:105-12.
20. Werb Z, Hembry RM, Murphy G, Aggeler J. Commitment to expression of the metalloendopeptidase, collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol 1986;102:697-702.
21. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271:30375-80.
22. Boyden PA, Tilley LP, Pham TD, Liu S-K, Fenoglio JJ, Witt AL. Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. Am J Cardiol 1982;49:1896-908.
23. Fenoglio JJ, Pham TD, Hordof A, Edie RN, Wit AL. Right atrial ultrastructure in congenital heart disease, II: atrial septal defect: effects of volume overload. Am J Cardiol 1979;43:820-7.
24. Driss AB, Devaux C, Henrion D, et al. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 2000;101:2764-70.
25. Mihm MJ, Fushun Y, Carnes CA, et al. Impaired myofibrillar energerics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-80.
26. Goette A, Arndt M, Rocken C, Spiess A, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000;101:2678-81.
27. Li D, Shinagawa K, Pang L, et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001;104:2608-14.
28. Shi Y, Li D, Tardif JC, Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 2002;54:456-61.
29. Podesser BK, Siwik DA, Eberli FR, et al. ETA-receptor blockade prevents matrix metalloproteinase activation of late postmyocardial infarction in the rat. Am J Physiol Heart Circ Physiol 2001;280:H984-91.
30. Wolf K, Sandner P, Kurtz A, Moll W. Messenger ribonucleic acid levels of collagenase (MMP-13) and matrilysin (MMP-7) in virgin, pregnant, and postpartum uterus and cervix of rat. Endocrinology 1996;137:5429-34.
31. Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (Pump-1), secreted from human rectal carcinoma cell line. Cancer Res 1991;50:7758-64.
32. Sires UI, Griffin GL, Broekelmann TJ, et al. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J Biol Chem 1993;268:2069-74.
33. Boyden PA, Tilley LP, Albala A, Liu SK, Fenoglio JJ, Wit AL. Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. Circulation 1984;69:1036-47.
34. Schoser BGH, Blottner D. Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle. Clin Neurosci 1999;10:2795-7.
35. Roten L, Nemoto S, Simsic J, et al. Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type I (TIMP-1) on left ventricular geometry and function in mice. J Mol Cell Cardiol 2000;32:109-20.
36. DiBattista JA, Pelletier JP, Zafarullah M, Iwata K, Martel-Pelletier J. Interleukin-1 beta induction of tissue inhibitor of metalloproteinase (TIMP-1) is functionally antagonized by prostaglandin E2 in human synovial fibroblasts. J Cell Biochem 1995;57:619-29.
37. Spach MS, Miller WT, Dolber PC, et al. The functional role of structural complexities in the propagation of depolarization in the atrium of the dog: cardiac conduction disturbances due to discontinuities of effective axial resistivity. Circ Res 1982;50:175-91.
38. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscles: evidence of electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 1986;58:356-71.
39. Kawara T, Derksen R, de Groot JR, et al. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 2001;104:3069-75.